Thalassemia refers to inherited hemoglobin disorders with reduced or absent globin-chain production, causing microcytic anemia and variable severity from asymptomatic carrier states to transfusion-dependent disease.
The FDA has approved Agios Pharmaceuticals' mitapivat (AQVESME) as the first oral treatment for anemia in thalassemia, reducing transfusion needs by 40-50%. Meanwhile, a clinical trial found a three-times-weekly dosing of vadadustat (Vafseo) is safe for kidney dialysis patients, potentially improving convenience.
Healthcare sector surged 10% since Q4 2025, outpacing all S&P 500 sectors as investors rotate from tech to pharmaceutical value plays. Major drugmakers demonstrate resilience following Medicare price negotiations implementation.
New treatments for rare pediatric neurological conditions show promise, with zorevunersen reducing seizures in Dravet syndrome patients and an SMA therapy under FDA review following stem cell research breakthroughs.
Bristol Myers Squibb's growth portfolio increased 17% in 2025, partially offsetting a 15% decline in legacy products facing generic competition. The company's stock gained 11.4% in the past month on strong fourth-quarter results.
March of Dimes awarded the 2026 Richard B Johnston Jr, MD Prize to hematologist Leonard Zon for pioneering zebrafish research that illuminated blood development in embryos and led to breakthrough treatments for genetic blood disorders in children.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07725263 |
Low-Dose Liposomal Amphotericin B for Invasive Fungal Infection Prophylaxis in Neutropenic Children |
RECRUITING | |
| NCT07698080 |
Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploidentical Hematopoietic Stem Cell Transplantation |
NOT_YET_RECRUITING | PHASE2 |
| NCT07673302 |
Safety and Efficacy of Hemoglobin F Inducers in Patients With Beta Thalassemia |
RECRUITING | NA |
| NCT07579949 |
A Study of SNH-119014 in Adult Participants With Non-transfusion-dependent Thalassemia (NTDT) |
NOT_YET_RECRUITING | PHASE2 |
| NCT07352878 |
Evaluation of the Quality of Life in Patients With Chronic Iron Overload Due to Hemoglobinopathies in Greece. |
NOT_YET_RECRUITING | |
| NCT07210450 |
Effect of L-Glutamine on Pulmonary Artery Pressure in Patients With Non-Transfusion-Dependent Thalassemia |
COMPLETED | PHASE2/PHASE3 |
| NCT07099196 |
Impact of Virtual Reality on Pain and Anxiety During Intravenous Cannulation Procedures Among Thalassemia Patients in UAE. |
COMPLETED | NA |
| NCT07064941 |
Effect of Exercise on Body Composition and Bone Health in Patients With Thalassemia |
ACTIVE_NOT_RECRUITING | NA |
| NCT07023029 |
A Study on the Effect of Etavopivat on Heart Rhythm in Healthy Participants |
COMPLETED | PHASE1 |
| NCT06889727 |
Pregnancy and Childbirth in Women with Thalassemia Yesterday and Today |
COMPLETED |
